Lawyers for three drug companies that won a California bench verdict last year in one of the first opioid trials in the nation referenced key themes in that decision in their opening statements on Monday in West Virginia.
Lawyers for Teva, Allergan and Janssen Pharmaceutical, in a bench trial in Charleston, West Virginia, argued that an oversupply of opioids did not prove they were liable for a public health crisis in the state. All three companies won a Nov. 1 decision in which a judge agreed, faulting three California counties and Oakland for failing to distinguish “medical inappropriate prescriptions” from legitimate ones in their own public nuisance case.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
